<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Alteration in the balance between cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and proliferation is one of the pathophysiological mechanisms of the <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The question of whether the excessive <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and/or proliferation predominantly involve the subset of progenitor cells (CD34(+) cells) or mature cells (CD34(-) cells) remains a controversial issue </plain></SENT>
<SENT sid="2" pm="."><plain>This study was purposed to analyze the <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and proliferation status of CD34(+) and CD34(-) cells in bone marrow (BM) of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, to investigate the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and to determine the relation of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and proliferation status of CD34(+) and CD34(-) cells with prognosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The proprotion of CD34(+) cells, the <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and proliferation ratio (A/P) of CD34(+) and CD34(-) cells in BM of 40 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, including 20 cases of high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and 20 cases of low-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, and 10 <z:mpath ids='MPATH_458'>normal</z:mpath> persons as control were detected by flow cytometry; the influence of CD34(+) and CD34(-) cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and proliferation levels on prognosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was evaluated by unvariate and multivariate analysis of survival </plain></SENT>
<SENT sid="4" pm="."><plain>The results showed that the proportion of CD34(+) cells in BM of high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients was significantly higher than that in BM of low-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients and in <z:mpath ids='MPATH_458'>normal</z:mpath> BM [(1.92 ± 0.10)%, (1.09 ± 0.04)%, (1.03 ± 0.05)% respectively] </plain></SENT>
<SENT sid="5" pm="."><plain>The apoptotic rates (AR) of both CD34(+) and CD34(-) cells were significantly higher in low-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> [(54.75 ± 2.18)%, (80.36 ± 1.68)%] than in high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> [(24.87 ± 2.69)%, (23.12 ± 1.23)%] and in <z:mpath ids='MPATH_458'>normal</z:mpath> BM [(18.51 ± 2.74)%, (20.98 ± 2.21)%] </plain></SENT>
<SENT sid="6" pm="."><plain>When compared between CD34(+) cells and CD34(-) cells in low-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, a greater AR of CD34(-) cells was found </plain></SENT>
<SENT sid="7" pm="."><plain>However, the higher proliferative rate of CD34(+) cells was observed in high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>In low-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, a higher A/P ratio was found in CD34(-) cells than in CD34(+) cells; whereas this ratio was equalized or inverted in high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, the survival and prognosis correlated significantly with AR of CD34(+) cells </plain></SENT>
<SENT sid="10" pm="."><plain>It is concluded that the early <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> is predominantly associated with excessive <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of the mature CD34(-) cells </plain></SENT>
<SENT sid="11" pm="."><plain>The proliferation rate of cells increases with the disease progression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> subsets, especially, in the subset of CD34(+) cells </plain></SENT>
<SENT sid="12" pm="."><plain>Surprisingly, the <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of CD34(+) cells may be a useful prognostic factor, and the inhibition of apoptotic mechanisms may induce the transformation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> to <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
</text></document>